London Pharmaceuticals & Research

London Pharmaceuticals & Research (LPR) was a specialty pharmaceutical company dedicated to the development of advanced topical treatments for dermatology and chronic wound care. Based in Princeton, New Jersey, the company focused on addressing unmet medical needs in the management of diabetic foot ulcers and other hard-to-heal lesions. Its lead clinical candidate, LPR-100, underwent Phase 2 clinical testing to evaluate its ability to accelerate wound closure and improve patient outcomes. The company utilized a research-intensive model, leveraging proprietary formulations to enhance the delivery of therapeutic agents to affected skin tissues. While active in the mid-2000s, the company has since become inactive, with no recent clinical or commercial developments reported.